NASDAQ:CLBT

Cellebrite DI (CLBT) Stock Price, News & Analysis

Cellebrite DI logo
$10.77 -0.55 (-4.86%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$11.10 +0.33 (+3.10%)
As of 11/20/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Cellebrite DI Stock (NASDAQ:CLBT)

Advanced

Key Stats

Today's Range
$10.72
▼
$11.41
50-Day Range
$10.65
▼
$12.70
52-Week Range
$9.58
▼
$19.39
Volume
2.71 million shs
Average Volume
2.35 million shs
Market Capitalization
$2.69 billion
P/E Ratio
44.88
Dividend Yield
N/A
Price Target
$14.75
Consensus Rating
Moderate Buy

Company Overview

Cellebrite DI Ltd. develops digital intelligence software and services that help organizations access, collect, preserve and analyze digital evidence. Its tools are used to investigate information from mobile devices, computers, cloud sources and other digital systems.

The company’s offerings include its UFED platform for extracting data from digital devices, Physical Analyzer for examining and interpreting evidence, and analytics and case-management tools such as Pathfinder and Guardian. Customers include law enforcement, public safety, intelligence and defense agencies, as well as organizations in the private sector.

Founded in Israel in 1999, Cellebrite serves customers around the world. The company became publicly traded on the Nasdaq in 2021.

AI Generated. May Contain Errors.

Cellebrite DI Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
82nd Percentile Overall Score

CLBT MarketRank™: 
4.11430575035 of 5 stars

Cellebrite DI scored higher than 82% of companies evaluated by MarketBeat, and ranked 180th out of 569 stocks in the technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cellebrite DI has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on no strong buy ratings, 4 buy ratings, no hold ratings, and 1 sell rating.

  • Upside Potential

    Cellebrite DI has a consensus price target of $14.75, representing about 37.0% upside from its current price of $10.77.

  • Amount of Analyst Coverage

    Cellebrite DI has only been the subject of 4 research reports in the past 90 days.

  • Read more about Cellebrite DI's stock forecast and price target.
  • Earnings Growth

    Earnings for Cellebrite DI are expected to grow by 37.84% in the coming year, from $0.37 to $0.51 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cellebrite DI is 44.88, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.18.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cellebrite DI is 44.88, which means that it is trading at a more expensive P/E ratio than the Technology sector average P/E ratio of about 41.15.

  • Price to Earnings Growth Ratio

    Cellebrite DI has a PEG Ratio of 1.36. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Cellebrite DI has a P/B Ratio of 4.64. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Cellebrite DI's valuation and earnings.
  • Percentage of Shares Shorted

    2.40% of the float of Cellebrite DI has been sold short.
  • Short Interest Ratio / Days to Cover

    Cellebrite DI has a short interest ratio ("days to cover") of 4.33.
  • Change versus previous month

    Short interest in Cellebrite DI has recently decreased by 21.86%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Cellebrite DI does not currently pay a dividend.

  • Dividend Growth

    Cellebrite DI does not have a long track record of dividend growth.

  • News Sentiment

    Cellebrite DI has a news sentiment score of 0.40. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Technology companies.
  • News Coverage This Week

    MarketBeat has tracked 15 news articles for Cellebrite DI this week, compared to 5 articles on an average week.
  • Search Interest

    4 people have searched for CLBT on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.
  • MarketBeat Follows

    Only 2 people have added Cellebrite DI to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cellebrite DI insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $761,343.00 in company stock.

  • Percentage Held by Insiders

    5.70% of the stock of Cellebrite DI is held by insiders.

  • Percentage Held by Institutions

    45.88% of the stock of Cellebrite DI is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Cellebrite DI's insider trading history.
Receive CLBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cellebrite DI and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CLBT Stock News Headlines

URGENT: If you own a home, please review the map below.
More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards urges homeowners to check the map and see whether one is near them. Families in Georgia have been forced to sell, entire Ohio neighborhoods are being torn down, and nearly 50,000 Lake Tahoe residents face losing power. Rickards advised the Pentagon and the U.S. intelligence community for decades. He says one man outside Washington can stop it.tc pixel
Cellebrite Cuts Workforce by 7%
Cellebrite Earnings Call Highlights Growth and Genesis Momentum
See More Headlines

CLBT Stock Analysis - Frequently Asked Questions

Cellebrite DI's stock was trading at $18.03 at the beginning of 2026. Since then, CLBT stock has decreased by 40.3% and is now trading at $10.77.

Cellebrite DI Ltd. (NASDAQ:CLBT) released its quarterly earnings results on Wednesday, February, 11th. The company reported $0.14 EPS for the quarter, meeting the consensus estimate of $0.14. The business's revenue was up 28.8% on a year-over-year basis.
Read the conference call transcript
.

Top institutional shareholders of Cellebrite DI include Phoenix Financial Ltd. (2.05%), Portolan Capital Management LLC (0.79%), State Street Corp (0.46%) and Tensile Capital Management LP (0.33%). Insiders that own company stock include Thomas E Hogan, Marcus Jewell, David Barter and David Nicholas Gee.
View institutional ownership trends
.

Shares of CLBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cellebrite DI investors own include NVIDIA (NVDA), Palantir Technologies (PLTR), Advanced Micro Devices (AMD), Uber Technologies (UBER), Alphabet (GOOG), Intel (INTC) and Tesla (TSLA).

Company Calendar

Today
11/22/2026
30th Annual UBS Global Technology and AI Conference
12/02/2026
Fiscal Year End
12/31/2026
Next Earnings (Estimated)
2/10/2027

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Software
Sub-Industry
Application Software
Current Symbol
NASDAQ:CLBT
CIK
1854587
Employees
1,285
Year Founded
1999

Price Target and Rating

High Price Target
$15.00
Low Price Target
$14.00
Potential Upside/Downside
+37.0%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.60
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.24
Trailing P/E Ratio
44.88
Forward P/E Ratio
21.12
P/E Growth
1.36
Net Income
$78.33 million
Net Margins
12.14%
Pretax Margin
15.42%
Return on Equity
16.91%
Return on Assets
9.03%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.66
Quick Ratio
1.65

Sales & Book Value

Annual Sales
$537.28 million
Price / Sales
5.00
Cash Flow
$0.40 per share
Price / Cash Flow
26.65
Book Value
$2.32 per share
Price / Book
4.64

Miscellaneous

Outstanding Shares
249,440,000
Free Float
235,222,000
Market Cap
$2.69 billion
Optionable
Optionable
Beta
1.06

Social Links

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

This page (NASDAQ:CLBT) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners